PubMed Health⌕ Search

Biomedical subjects

Paweł Zagrodzki

Publications and source records attributed to Paweł Zagrodzki.

3 recordsLinked to original sources

[Selenium and cardiovascular disease: selected issues].

The paper presents current knowledge of the role of selenium in the development of cardiovascular system disease (CSD). Already known mechanisms of selenium action in the cardiovascular system are described, whilst underlining the fact that they do not explain all relevant observations and need to be clarified by more studies. Clinical, epidemiological, and experimental studies devoted to the relationship between the progression of CSD and selenium status indices are then reviewed. It could be expected that any explanation of the pathophysiological mechanisms of the influence of tobacco smoking (as one of the classical risk factors for CSD) on selenium status might help to bring about a better understanding of the progression of cardiovascular disorders. Based on studies conducted on animal models, the role of selenium in the antioxidant defense of cardiac muscle is described. Particular attention is paid to a dilated cardiomyopathy known as Keshan disease, for which it has been shown that selenium deficiency is an environmental factor predisposing to the onset of this disease. Similar symptoms of cardiomyopathy are also observed in patients on total parenteral nutrition and patients with AIDS.

Acquired Immunodeficiency Syndrome↗

[Selenium and the immune system].

The paper presents the current knowledge about the role of the trace element selenium in the immune system, and possible mechanisms of its action during the immune response. Investigations to date, based on animal and human models, have delivered increasing evidence of Se involvement in the functioning of the immune system. Recently, the importance of selenium in the progression of some viral diseases (e.g. AIDS) has been revealed. However, several questions remain to be explained, such as the turnover of selenium compounds in the cells of the immune system, since no complete theoretical framework yet exists at the molecular level. The problem of the influence of dietary selenium (included in the normal diet, or a diet only slightly modified with selenium) on human immune functions also needs to be resolved.

Animals↗

[Thioredoxin reductase--a new target for molecular medical investigations].

Thioredoxin reductase (TrxR) is the first selenoenzyme containing selenocysteine in the active center and FAD as a second prosthetic group. TrxR catalyses the NADPH-dependent reduction of thioredoxin and of many other physiologically important substrates. TrxR exhibits a many-fold increase in the activity in tumor cells and stimulates their proliferation as well the phenotype changes. Some gold compounds and a number of other clinically and experimentally tested drugs have been shown to inhibit TrxR. The involvement of TrxR/Trx/NADPH system in a broad spectrum of cellular processes renders it a potential target for therapeutic approaches.

Animals↗